Panascope operates as an independent brand with full control of its technology, quality systems, and customer relationships. Governance is not extra bureaucracy. It is the structure that keeps every major decision aligned with one goal, patient safety.
Since 2007 Panascope has used a lean but strict governance model. Shareholders appoint a board of directors for strategic oversight. The board brings experience in medical physics, radiology operations, regulatory work, and international business. This ensures that product decisions stay grounded in clinical reality rather than short term commercial aims.
Panascope uses specialized committees within the board that match the scale of the company.
The audit committee oversees financial reporting, internal controls, and external audits, keeping financial integrity aligned with image integrity.
The nomination committee maintains the right mix of skills and independence on the board and identifies candidates who understand diagnostic imaging.
The compensation committee aligns executive rewards with long term value such as system uptime, customer satisfaction, and dose reduction.
The board appoints executive officers to carry out the strategic plan. They are supported by a quality and imaging safety committee that reviews image quality issues, radiation events, and MRI safety matters, and by a risk and compliance panel that monitors regulatory changes, supplier audits, and field corrections. An independent internal audit function reports to the audit committee.
Based in Shenzhen, Panascope applies these governance principles across all markets. A lean structure does not weaken governance. It makes decisions visible, risks owned, and leaders accessible.
Governance is not a chart. It is a commitment to the people who rely on Panascope images, including patients awaiting diagnosis, radiologists reading each image, technologists operating the systems, and administrators managing limited resources.
Panascope is led by its founders and an executive team, with strategic direction reviewed by a board of directors. The board ensures that long term plans for products, technology, and markets stay aligned with core values and patient safety.
A quality and imaging safety committee reports to the board. It reviews image quality issues, radiation safety events, inspection findings, and MRI safety matters. The committee meets quarterly to keep quality and safety above commercial pressure.
Three principles guide all decisions: transparency, accountability, and priority for patient safety. Design reviews, supplier selection, field corrections, and post market surveillance are documented and auditable. Accountability extends to the radiologists and patients who rely on each image.
Panascope operates under a certified quality system aligned with ISO standards for medical devices. Risk management follows recognized methods with focus on imaging hazards such as radiation, magnetic field safety, electrical safety, and contrast reactions.
Regulatory registrations in China, the EU, and other regions are maintained directly by Panascope. Compliance is daily discipline through document control, training, and process adherence.
Because Panascope controls its technology and production, it also controls supplier qualification. Annual on site audits check adherence to quality standards for CT, MRI, and related systems. No component enters a Panascope system without internal verification.
Panascope views radiologists, technologists, administrators, distributors, regulators, employees, and partners as key stakeholders. Engagement includes user feedback during testing, post installation surveys, open channels for field reports, and regular reviews with production partners. Panascope is not distant. It is an accessible team that listens, because listening leads to real improvement.
Subscribe to exclusive imaging insights & priority updates from Panascope. Elevate your practice with curated intelligence.
© Nortek HealthCare Group Ltd., 2009-2026. All rights reserved.
This site operates under the laws of the People's Republic of China. Your access and use constitute acceptance of these Terms of Use and our Privacy Policy. All content is governed by our Privacy Notice. For details or inquiries, please Contact Us or use the site's search function.
